INVESTABOT
Equity Research
XNYS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Ventas (VTR) had 1 Form 144 pre-sale notice filed on 2026-05-14. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
TL;DR: Peter J. Bulgarelli, Executive Vice President of Outpatient Medical & Research at Ventas, officially separated from the company following his retirement on May 1, 2026. The departure was pre-announced, and a…
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 0 unique sellers · 7 accumulating - 6 trimming - 1 unchanged
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| August 1, 2026 | Wattula Andy | EVP OM&R-Ventas/Pres&CEO-LHS | GRANT | 10,694 | $94 | ~$1.0M |
| August 1, 2026 | Wattula Andy | EVP OM&R-Ventas/Pres&CEO-LHS | GRANT | 4,314 | $94 | ~$0.4M |
| July 16, 2026 | Smith Maurice S | — | GRANT | 56.2 | $95 | ~$5K |
| July 16, 2026 | Smith Maurice S | — | GRANT | 71.62 | $95 | ~$7K |
| July 16, 2026 | Roy Sumit | — | GRANT | 47.09 | $95 | ~$4K |
| July 16, 2026 | Roy Sumit | — | GRANT | 71.62 | $95 | ~$7K |
| July 16, 2026 | Nader Marguerite M | — | GRANT | 71.62 | $95 | ~$7K |
| July 16, 2026 | Rodriguez Joe Vasquez Jr. | — | GRANT | 48.51 | $95 | ~$5K |
| July 16, 2026 | Martino Roxanne M | — | GRANT | 173.89 | $95 | ~$17K |
| July 16, 2026 | Lustig Matthew J | — | GRANT | 209.67 | $95 | ~$20K |
| July 16, 2026 | Lustig Matthew J | — | GRANT | 71.62 | $95 | ~$7K |
| July 16, 2026 | Embler Michael J | — | GRANT | 71.62 | $95 | ~$7K |
| July 16, 2026 | Barnes Melody C | — | GRANT | 71.62 | $95 | ~$7K |
| July 1, 2026 | Martino Roxanne M | — | GRANT | 543.78 | $90 | ~$49K |
| July 1, 2026 | Smith Maurice S | — | GRANT | 460.89 | $90 | ~$41K |
| July 1, 2026 | Lustig Matthew J | — | GRANT | 447.71 | $90 | ~$40K |
| July 1, 2026 | Roy Sumit | — | GRANT | 348.58 | $90 | ~$31K |
| June 3, 2026 | Embler Michael J | — | BUY | 2,500 | $79 | ~$0.2M |
| May 14, 2026 | Rakowich Walter C | — | SELL | -1,152 | $90 | ~$0.1M |
| May 13, 2026 | Smith Maurice S | — | GRANT | 2,047 | $90 | ~$0.2M |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| May 14, 2026 | J.P. Morgan Securities LLC as agent and attorney-in-fact for Walter C. Rakowich | — | — | SEC |
| Date | Insider | Title | Relationship | Shares | Filing |
|---|---|---|---|---|---|
| August 4, 2026 | — | — | — | — | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 75,948,003 | ~$5.9B | — | January 29, 2026 |
| BlackRock | 55,781,968 | ~$5.0B | -1.4% | August 7, 2026 |
| BlackRock | 56,582,774 | ~$4.6B | 2.7% | May 13, 2026 |
| BlackRock | 55,092,985 | ~$4.3B | — | February 12, 2026 |
| JP Morgan Chase | 43,693,905 | ~$3.9B | 22.8% | August 12, 2026 |
| JP Morgan Chase | 35,579,149 | ~$2.9B | 25.4% | May 13, 2026 |
| State Street | 30,526,195 | ~$2.7B | 2.4% | August 7, 2026 |
| State Street | 29,798,498 | ~$2.5B | 0.5% | May 15, 2026 |
| Fidelity (FMR) | 26,246,531 | ~$2.3B | -3.7% | August 13, 2026 |
| State Street | 29,662,635 | ~$2.3B | — | February 13, 2026 |
| Fidelity (FMR) | 29,281,079 | ~$2.3B | — | February 17, 2026 |
| Fidelity (FMR) | 27,251,339 | ~$2.2B | -6.9% | May 15, 2026 |
| BlackRock | 43,295,150 | ~$2.2B | — | August 13, 2024 |
| JP Morgan Chase | 28,376,464 | ~$2.2B | — | February 11, 2026 |
| Morgan Stanley | 7,885,794 | ~$700.3M | 23.5% | August 13, 2026 |
| Morgan Stanley | 6,387,470 | ~$522.4M | 0.7% | May 15, 2026 |
| Morgan Stanley | 6,344,347 | ~$490.9M | — | May 27, 2026 |
| Goldman Sachs | 4,813,407 | ~$427.4M | 14.3% | August 14, 2026 |
| Goldman Sachs | 4,211,923 | ~$344.5M | 2.7% | May 15, 2026 |
| Two Sigma | 4,002,405 | ~$327.3M | 146.3% | May 15, 2026 |